Home Dialysis News

NxStage Kidney Care Inc., a subsidiary of NxStage Medical Inc. has opened a new dialysis center in Jacksonville, Fla. The center is certified to provide home hemodialysis, peritoneal dialysis, and in-center dialysis. The Jacksonville facility is the second dialysis center for the company. It opened its first dialysis center outside St. Louis in Des Peres, Mo. in October 2013.

Debiotech of Switzerland, AWAK of Singapore, and Neokidney Development, an initiative of the Dutch Kidney Foundation, have signed a joint venture agreement to develop a miniaturized home hemodialysis machine. This new system will be based on Debiotech's miniaturized peritoneal dialysis equipment DialEase, and AWAK's novel sorbent technology for fluid purification. Neokidney Development will provide access to the Dutch Kidney Foundation's medical expertise and network of internationally acclaimed nephrologists and patient organizations, and will mobilize funding from public and private sources, including health insurers and social impact investors, according to a news release. 

Mar Cor Purification, a subsidiary of Cantel Medical has been given 510(k) clearance from the U.S. Food and Drug Administration for the BioPure HX2, a heat disinfectable central reverse osmosis (RO) water system for dialysis. The BioPure HX2 is a Double Pass RO with automatic hot water disinfection with four different modes. Mar Cor had previously been awarded a Class 3 Device License from Health Canada in 2013 for the system, which has been available in the Canadian and international markets for more than a year.

Dialysis provider DaVita Kidney Care said it has started delivering hemodiafiltration treatments to select patients in Colorado Springs as part of a six-month trial program. This program is the first commercial use of hemodiafiltration in the United States.

Dialysis product manufacturer NxStage Medical Inc. reported revenue for the first quarter of 2014 increased 17% to $72.2 million, compared with revenue of $61.6 million in the same quarter last year. The company exceeded its revenue guidance range of $69.5 to $70.5 million for the first quarter of 2014. NxStage attributed the increase to strong sales of itsSystem One hemodialysis machine in both the home dialysis and critical care markets.

A research group formed by the North American chapter of the International Society for Peritoneal Dialysis has landed funding for its first project.

The Centurion portable dialysis water treatment system from AmeriWater has been approved for marketing by the U.S. Food and Drug Administration for use in medical facilities or at home. The integrated heat disinfection design of the Centurion disinfects the entire unit in a single step – including the membrane and the delivery lines up to the inlet of the dialysis machine, according to AmeriWater.

LAS VEGAS – Patients treated on-site in a nursing home setting with daily home hemodialysis had lower monthly mortality rates and longer median survival when compared to conventional thrice-weekly dialysis, according to new research presented at the 2014 National Kidney Foundation Spring Clinical Meetings. Affiliated Dialysis Centers LLC, an independent dialysis provider based in Illinois, shared the release of clinical data in a Late Breaking Poster Session at the 2014 National Kidney Foundation Spring Clinical Meetings here. Xelay Acumen, a strategy and medical data analytics firm, independently led the data collection and analysis effort, and Dr. Alex Yang, MD, presented the results.

With Medicare offering financial incentives in the end-stage renal disease payment bundle to expand home programs, peritoneal dialysis has become a favored choice because it is simpler and cheaper than home hemodialysis. NxStage Medical, which has helped to rejuvenate interest in home hemodialysis, is now throwing its hat into the ring, saying it will develop new products for the peritoneal dialysis market in 2014.

Home Dialyzors United is expanding its board of director and committee leadership, the home dialysis patient organization announced on its website. HDU is soliciting applications from patients and care partners who are passionate about promoting home therapies through education, networking, and advocacy. Besides seeking another board member following the untimely death of Kathe LeBeau, HDU is also searching for persons with expertise in accounting, law, public relations, marketing, computer technology including Word Press, industry relations, membership, fund raising, grant writing and more.